Oric Pharmaceuticals, Inc. Insider Trading for April 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oric Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Oric Pharmaceuticals, Inc. for April 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 151,515 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 416,666 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 625,000 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 3,500,000 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 151,515 | 0 | 4,768,181 | 4.6 M to 4.8 M (+3.28 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 416,666 | 0 | 4,616,666 | 4.2 M to 4.6 M (+9.92 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 625,000 | 0 | 4,200,000 | 3.6 M to 4.2 M (+17.48 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 3,500,000 | 0 | 3,575,000 | 75 K to 3.6 M (+4,666.67 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 236,111 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 373,356 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,875,000 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 236,111 | 0 | 2,765,717 | 2.5 M to 2.8 M (+9.33 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 373,356 | 0 | 2,529,606 | 2.2 M to 2.5 M (+17.32 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,875,000 | 0 | 2,156,250 | 281.3 K to 2.2 M (+666.67 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 281,250 | 4,500,000 | 281,250 | 0 to 281.3 K |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,268,750 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 314,815 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 497,809 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 231,250 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Buy | C | 0.00 | 2,268,750 | 0 | 2,268,750 | 0 to 2.3 M |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Buy | C | 0.00 | 314,815 | 0 | 1,043,874 | 729.1 K to 1 M (+43.18 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Buy | C | 0.00 | 497,809 | 0 | 729,059 | 231.3 K to 729.1 K (+215.27 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Buy | C | 0.00 | 231,250 | 0 | 231,250 | 0 to 231.3 K |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 151,515 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 416,666 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 625,000 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 3,500,000 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Buy | C | 0.00 | 151,515 | 0 | 4,768,181 | 4.6 M to 4.8 M (+3.28 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Buy | C | 0.00 | 416,666 | 0 | 4,616,666 | 4.2 M to 4.6 M (+9.92 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Buy | C | 0.00 | 625,000 | 0 | 4,200,000 | 3.6 M to 4.2 M (+17.48 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Buy | C | 0.00 | 3,500,000 | 0 | 3,575,000 | 75 K to 3.6 M (+4,666.67 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Buy | C | 0.00 | 25,000 | 0 | 50,000 | 25 K to 50 K (+100.00 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Option Exercise | C | 0.00 | 62,500 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Buy | C | 0.00 | 62,500 | 0 | 227,500 | 165 K to 227.5 K (+37.88 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 236,111 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 373,356 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,875,000 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | C | 0.00 | 236,111 | 0 | 2,765,717 | 2.5 M to 2.8 M (+9.33 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | C | 0.00 | 373,356 | 0 | 2,529,606 | 2.2 M to 2.5 M (+17.32 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,875,000 | 0 | 2,156,250 | 281.3 K to 2.2 M (+666.67 %) |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | P | 16.00 | 281,250 | 4,500,000 | 281,250 | 0 to 281.3 K |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Option Exercise | C | 0.00 | 62,500 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Buy | C | 0.00 | 62,500 | 0 | 62,500 | 0 to 62.5 K |
| Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Multani Pratik S | Chief Medical Offic ... | Option Exercise | A | 16.00 | 147,500 | 2,360,000 | 147,500 | |
| Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Piscitelli Dominic | Chief Financial Off ... | Option Exercise | A | 16.00 | 86,250 | 1,380,000 | 86,250 | |
| Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Dier Mardi | Director | Option Exercise | A | 16.00 | 33,250 | 532,000 | 33,250 | |
| Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | A | 16.00 | 16,625 | 266,000 | 16,625 | |
| Apr 27 2020 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Option Exercise | A | 16.00 | 33,250 | 532,000 | 33,250 | |
| Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Option Exercise | A | 16.00 | 16,625 | 266,000 | 16,625 | |
| Apr 27 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | A | 16.00 | 16,625 | 266,000 | 16,625 | |
| Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Option Exercise | A | 16.00 | 437,500 | 7,000,000 | 437,500 |